CERT 10.71 (+1.52%)
US15687V1098BiotechnologyBiotechnology

Certara (CERT) Stock Highlights

10.71 | +1.52%
2024-12-21 03:43:46
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States.

Statistics

Range Today
10.51 11.05
Volume Today 3.24M
Range 1 Year
9.41 19.87
Volume 1 Year 210.01M
Range 3 Year
9.41 29.99
Volume 3 Year 634.3M
Range 10 Year
9.41 45.48
Volume 10 Year 855.24M

Highlights

Market Capitalization 1.78B (small)
Floating Shares 110.72M
Current Price 10.71
Price To Earnings -55.25
Price To Revenue 4.95
Price To Book 1.68
Earnings Per Share -0.2
Payout Ratio 0%

Performance

Latest +1.52%
1 Month +8.18%
3 Months -5.22%
6 Months -19.29%
1 Year -38.55%
3 Years -60.24%
5 Years -64.18%
10 Years -64.18%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.